Publications by authors named "Eva Distler"

Claim this Profile
P
Patient-individualized CD8⁺ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice.
Eva Distler, Jana Albrecht, Ariane Brunk, Shamsul Khan, Elke Schnürer

Int J Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticles and antigen-specific T-cell therapeutics: a comprehensive study on uptake and release.
Oliver Zupke, Eva Distler, Anna Jürchott, Umaporn Paiphansiri, Martin Dass

Nanomedicine (Lond)· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines.
Benedict R Halbroth, Alexander Heil, Eva Distler, Martin Dass, Eva M Wagner

PLoS One· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients.
Maikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, Daniel Portsmouth, Richard Fritz, Eva Distler

Clin Vaccine Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro.
Thomas Nerreter, Eva Distler, Carolin Köchel, Hermann Einsele, Wolfgang Herr

Exp Hematol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation.
Patrick Kleemann, Eva Distler, Eva M Wagner, Simone Thomas, Sebastian Klobuch

Haematologica· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.
Eva Distler, Andrea Bloetz, Jana Albrecht, Saliha Asdufan, Alexander Hohberger

Haematologica· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype.
Jana Albrecht, Michaela Frey, Daniel Teschner, Alexander Carbol, Matthias Theobald, Eva Distler

Cancer Immunol Immunother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Eva Distler, Elke Schnürer, Eva Wagner, Charis von Auer, Bodo Plachter

Biol Blood Marrow Transplant· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression.
Thomas C Wehler, Michael Karg, Eva Distler, Abdo Konur, Marion Nonn

J Immunol Methods· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Marion Nonn, Wolfgang Herr, Shamsul Khan, Mariya Todorova, Irina Link, Eva Distler

Transplantation· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Eva Distler, Catherine Wölfel, Sylvia Köhler, Marion Nonn, Nina Kaus

Exp Hematol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis